In line with these experimental findings, other authors also reported a diminishing impact of 11β-HSD1 inhibition on TNF-α and interleukin-6 production [56], which is also associated with NASH/MASH [57]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.